'Eli Lilly Has Hired CordenPharma To Make Active Ingredient For Mounjaro' - Reuters News
Portfolio Pulse from Benzinga Newsdesk
Eli Lilly has contracted CordenPharma, a Switzerland-based drugmaker, to produce the active ingredient for its diabetes drug Mounjaro.
October 19, 2023 | 5:59 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Eli Lilly's partnership with CordenPharma for the production of Mounjaro's active ingredient could potentially streamline production and improve supply chain efficiency.
The partnership with CordenPharma could potentially improve Eli Lilly's production efficiency and supply chain for Mounjaro. This could lead to cost savings and increased availability of the drug, potentially boosting Eli Lilly's revenues and positively impacting its stock price in the short term.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100